GeneDx Holdings Corp (NASDAQ: WGS) is a genomic diagnostics company that provides whole genome and exome sequencing services, primarily for pediatric and rare disease diagnosis. The filing excerpts from the 10-K filed 2026-02-23 (accession 000181833126000015) do not contain sufficient detail to characterize revenue streams, segment breakdowns, customer counts, competitive positioning, geographic footprint, founding history, or leadership with the specificity required for a fully grounded description. Based solely on the available filing excerpts, a complete canonical description cannot be constructed without risk of introducing unsupported facts. The company files annually with the SEC under ticker WGS and is registered under Section 12(b) of the Exchange Act.

Source: SEC 10-K, filed 2026-02-23

Industry: Services-Health Services Peers: AirSculpt Technologies Inc ATI Physical Therapy, Inc. Aveanna Healthcare Holdings Inc CareMax, Inc. Castle Biosciences Inc CVS Health Corp Enhabit Inc Invitae Corp